Debien V, Agostinetto E, Bruzzone M, Ceppi M, et al. The Impact of Initial Tumor Response on Survival Outcomes of Patients With HER2-Positive Advanced Breast Cancer Treated With Docetaxel, Trastuzumab, and Pertuzumab: An Exploratory Analysis of the CLEOPATRA Trial. Clin Breast Cancer 2024 Feb 21:S1526-8209(24)00050.
PMID: 38514306